RxDoctor Payments DataLook up a doctor →

PHENTOLAMINE MESYLATE: payments to doctors

Payments that named PHENTOLAMINE MESYLATE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$15K
Providers
12
Transactions
12
Average per transaction
$1,251

The per-transaction average — $1,251 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12 providers the average total is $1,251, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Oyster Point Pharma, Inc.$15,010100.0%
← All drugs & devices